personal genome service - Search News

Order byBest matchMost fresh

News

23andMe Found a Buyer for Our Genetic Data

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction for key assets of 23andMe Holding Co. in a $256 million deal to boost its genetics-based drug discovery efforts.

Continue reading

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

ConsumerAffairs · 4d

Regeneron buys 23andMe out of bankruptcy, sparking genetic data privacy concerns

2d

23andMe sale reveals what your genetic data is worth. It’s less than you think

The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...

The Hudson Independent1d

Regeneron Enters into Agreement to Acquire Consumer Genetics Business

Tarrytown-based Regeneron Pharmaceuticals, Inc. has announced it has been named the successful bidder in the bankruptcy ...

Regeneron to acquire 23andMe for $256M, plans to continue consumer genetics services

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

4don MSN

Regeneron to buy 23andMe out of bankruptcy for $256 million

Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's ...

Contract Pharma3d

Regeneron in Deal to Acquire 23andMe for $256M

To acquire Personal Genome Service, Total Health and Research Services business lines, and its Biobank and associated assets.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results